Superworth

DENTSPLY SIRONA price to free cash flow XRAY

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026
13.1×
10-year median
22.9×
Against its 10-year history
10th
percentile: 0 is its lowest day, 100 its highest
10-year range
9.0× to 47.0×
Peer median
28.1×

DENTSPLY SIRONA's price to free cash flow is 13.1× as of Oct 23, 2026.

That is below its ten-year median of 22.9×, lower than on 90% of days in the last ten years.

Over that time it ranged from 9.0× in Apr 2025 to 47.0× in Jun 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 28.1×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far13.1×11.9×34.3×
202528.7×9.0×28.9×
202410.3×9.7×35.5×
202334.6×16.4×41.5×
202215.6×11.5×22.5×
202121.4×19.1×27.0×
202019.9×14.3×33.6×
201931.9×24.8×47.0×
201823.6×18.9×34.6×
201733.5×27.4×39.4×
201636.2×16.3×42.1×
201517.5×15.2×18.2×
201417.8×15.8×21.5×
201321.2×19.7×24.1×
201221.9×16.3×22.7×
201116.2×13.3×17.3×
201015.0×11.9×15.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest DENTSPLY SIRONA's size, closest first, today.

CompanyPrice to free cash flow
XRAYDENTSPLY SIRONA13.1×
LMATLemaitre Vascular26.2×
INSPInspire Medical Systems17.6×
UFPTUFP Technologiesn/m
EYENational Vision30.1×
CDRECadre16.4×
BVSBioventus13.3×
ATRCAtriCure56.5×
STAAStaar Surgicaln/m
WRBYWarby Parker147×
IRMDIradimed43.7×
Peer median28.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on DENTSPLY SIRONA

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.